141 related articles for article (PubMed ID: 17491213)
1. Late in-hospital pressure gradient measurements improve prediction of long-term outcome of alcohol septal ablation in hypertrophic cardiomyopathy.
Keren A; Poteckin M; Mazouz B; Medina A; Banai S; Chenzbraun A; Khoury Z; Levin G
Isr Med Assoc J; 2007 Apr; 9(4):239-42. PubMed ID: 17491213
[TBL] [Abstract][Full Text] [Related]
2. The biphasic course of changes of left ventricular outflow gradient after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Duchonová R; Procházková S; Homolová I; Pálenícková J; Zemánek D; Pernisová Z; Tesar D
Kardiol Pol; 2004 Feb; 60(2):133-6; discussion 137. PubMed ID: 15116158
[TBL] [Abstract][Full Text] [Related]
3. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
[TBL] [Abstract][Full Text] [Related]
4. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
[TBL] [Abstract][Full Text] [Related]
5. Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Yoerger DM; Picard MH; Palacios IF; Vlahakes GJ; Lowry PA; Fifer MA
Am J Cardiol; 2006 May; 97(10):1511-4. PubMed ID: 16679095
[TBL] [Abstract][Full Text] [Related]
6. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Jassal DS; Neilan TG; Fifer MA; Palacios IF; Lowry PA; Vlahakes GJ; Picard MH; Yoerger DM
Eur Heart J; 2006 Aug; 27(15):1805-10. PubMed ID: 16774986
[TBL] [Abstract][Full Text] [Related]
7. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
8. [Doppler echocardiographic evaluation of left ventricular diastolic function in patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation in acute and long-term follow up].
Wojtarowicz A; Kornacewicz-Jach Z; Kaźmierczak J; Szamlewski P; Gil R; Lewandowski M
Pol Merkur Lekarski; 2002 Jul; 13(73):25-8. PubMed ID: 12362500
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.
Veselka J; Jensen MK; Liebregts M; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Tomasov P; Adlova R; Bundgaard H; Steggerda R; Ten Berg J; Faber L
Eur Heart J; 2016 May; 37(19):1517-23. PubMed ID: 26746632
[TBL] [Abstract][Full Text] [Related]
11. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: technical review and long-term clinical and echocardiographic outcomes.
Leal S; Galeote G; Jiménez-Valero S; Sánchez-Recalde A; Salinas P; Ruiz AS; Orbe LC; Dominguéz F; Moreno R; López-Sendón JL
Rev Port Cardiol; 2012 May; 31(5):363-71. PubMed ID: 22482474
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.
Lu M; Du H; Gao Z; Song L; Cheng H; Zhang Y; Yin G; Chen X; Ling J; Jiang Y; Wang H; Li J; Huang J; He Z; Zhao S
Circ Cardiovasc Interv; 2016 Mar; 9(3):e002675. PubMed ID: 26884612
[TBL] [Abstract][Full Text] [Related]
14. Effect of alcohol-induced septal ablation on left atrial volume and ejection fraction assessed by real time three-dimensional transthoracic echocardiography in patients with hypertrophic cardiomyopathy.
Hage FG; Karakus G; Luke WD; Suwanjutah T; Burri MV; Nanda NC; Aqel RA
Echocardiography; 2008 Aug; 25(7):784-9. PubMed ID: 18754938
[TBL] [Abstract][Full Text] [Related]
15. Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients.
Aqel RA; Hage FG; Zohgbi GJ; Tabereaux PB; Lawson D; Heo J; Perry G; Epstein AE; Dell' Italia LJ; Iskandrian AE
Am J Cardiol; 2008 May; 101(9):1328-33. PubMed ID: 18435966
[TBL] [Abstract][Full Text] [Related]
16. Quantification of changes in septal strain after alcohol septal ablation in hypertrophic obstructive cardiomyopathy-cases from the three-dimensional speckle tracking echocardiographic MAGYAR-path study.
Nemes A; Domsik P; Kalapos A; Gavallér H; Forster T; Sepp R
Echocardiography; 2013 Oct; 30(9):E289-91. PubMed ID: 23808936
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H; Rigopoulos A; Welge D; Ziemssen P; Faber L
Clin Res Cardiol; 2007 Dec; 96(12):856-63. PubMed ID: 17891517
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
Alam M; Dokainish H; Lakkis NM
Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
[TBL] [Abstract][Full Text] [Related]
19. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Almasood A; Garceau P; Woo A; Rakowski H; Schwartz L; Overgaard CB
JACC Cardiovasc Interv; 2011 Sep; 4(9):1030-4. PubMed ID: 21939945
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Non-Left Anterior Descending Septal Perforator Culprit in Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation.
Alkhouli M; Sajjad W; Lee J; Fernandez G; Waits B; Schwarz KQ; Cove CJ
Am J Cardiol; 2016 May; 117(10):1655-1660. PubMed ID: 27006152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
